Respiratory distress syndrome and its treatment with surfactant. 1985

C J Morley

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011663 Pulmonary Surfactants Substances and drugs that lower the SURFACE TENSION of the mucoid layer lining the PULMONARY ALVEOLI. Surfactants, Pulmonary,Pulmonary Surfactant,Surfactant, Pulmonary
D012127 Respiratory Distress Syndrome, Newborn A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause. Infantile Respiratory Distress Syndrome,Neonatal Respiratory Distress Syndrome,Respiratory Distress Syndrome, Infant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C J Morley
March 1999, Archives of disease in childhood,
C J Morley
March 1991, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
C J Morley
November 1990, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
C J Morley
January 2006, Anesteziologiia i reanimatologiia,
C J Morley
July 1978, Praxis und Klinik der Pneumologie,
C J Morley
January 1996, The Turkish journal of pediatrics,
C J Morley
June 2003, American journal of respiratory and critical care medicine,
C J Morley
August 1986, The Western journal of medicine,
C J Morley
April 2000, Lancet (London, England),
Copied contents to your clipboard!